ICD-10-CM · Multi-region

M85.19

Skeletal fluorosis affecting two or more distinct anatomical sites simultaneously, classified under disorders of bone density and structure.

Verified May 8, 2026 · 5 sources ↓

Status
Billable
Chapter
13
Related CPT
12
Region
Multi-region
Drawn from CDCCMSAAPCicd10data.com 2026

Documentation tips

What should appear in the chart to support M85.19.

Source · Editorial brief grounded in 5 cited references ↓

  • Explicitly name each affected anatomical site in the assessment — 'skeletal fluorosis of the spine and bilateral lower extremities' is sufficient; 'multiple sites' alone mirrors the unspecified language and should be avoided without further detail.
  • Record the fluoride exposure source (endemic water, industrial exposure, iatrogenic) to support medical necessity and distinguish from metabolic bone disease mimics.
  • Document radiographic findings by site: osteosclerosis grade, periosteal reaction, ligament calcification, and any cortical thickening on plain films or CT.
  • Note any functional impairment, restricted range of motion, or neurologic compromise from canal narrowing, as these findings support medical necessity for advanced imaging and specialist referral.
  • If serum or urinary fluoride levels were obtained, include results in the record to corroborate the diagnosis, particularly when the exposure history is uncertain.

Related CPT procedures

Procedure codes commonly billed with M85.19. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M85.19 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

  • Defaulting to M85.19 when only one site is documented — review the note carefully and assign the site-specific M85.1xx code instead; M85.19 is reserved for genuinely polyostotic involvement.
  • Failing to check the Excludes1 list under M85 before coding: polyostotic fibrous dysplasia (Q78.1) and osteopetrosis (Q78.2) can radiographically mimic multi-site fluorosis but are hard-blocked from being coded alongside M85.19.
  • Confusing M85.19 (multiple sites) with M85.18 (other site) — 'other site' applies to a single anatomical location not listed in the site-specific subcategories, not to more than one site.
  • Omitting a secondary code for the underlying exposure when relevant (e.g., a Z-code for occupational exposure history), which can weaken the clinical narrative and risk-adjustment record.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

M85.19 applies when skeletal fluorosis is documented at multiple discrete sites — for example, concurrent involvement of the spine and lower extrembs, or upper and lower limb bones together. Use M85.19 only when the record explicitly identifies more than one affected region; if fluorosis is confined to a single named site, select the corresponding site-specific code within M85.1x (e.g., M85.151/M85.152 for thigh, M85.161/M85.162 for lower leg). If only one site is affected but laterality is unspecified, use M85.10 (unspecified site).

Skeletal fluorosis results from chronic excessive fluoride exposure — historically through endemic high-fluoride groundwater, industrial inhalation, or prolonged high-dose therapeutic fluoride use. Radiographic findings drive the diagnosis: osteosclerosis, periosteal new bone formation, ligament calcification, and cortical thickening are characteristic. The spine, pelvis, and long bones are most commonly involved, which is why multi-site presentation is the clinical norm rather than the exception.

M85.19 maps to MDC 08 (Diseases & Disorders of the Musculoskeletal System & Connective Tissue) under MS-DRG grouping per CMS v37.2. The M85 category carries an Excludes1 note blocking concurrent use with osteogenesis imperfecta (Q78.0), osteopetrosis (Q78.2), osteopoikilosis (Q78.8), and polyostotic fibrous dysplasia (Q78.1) — verify none of these apply before assigning M85.19.

Sibling codes

Other billable codes under M85.1 (laterality / anatomic variants).

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 5 cited references ↓

01When should I use M85.19 instead of a site-specific M85.1 code?
Use M85.19 only when the provider documents fluorosis at two or more distinct anatomical sites. If a single site is clearly identified — even if bilateral — select the matching site-specific code with the appropriate laterality digit.
02What is the difference between M85.18 and M85.19?
M85.18 (other site) applies to skeletal fluorosis at a single anatomical location that doesn't have its own dedicated subcategory in M85.1. M85.19 applies when two or more sites are simultaneously involved. Do not use M85.18 as a stand-in for multi-site disease.
03Does M85.19 have any Excludes notes I need to check?
Yes. The M85 category carries Excludes1 notes for osteogenesis imperfecta (Q78.0), osteopetrosis (Q78.2), osteopoikilosis (Q78.8), and polyostotic fibrous dysplasia (Q78.1). These codes cannot be assigned together with any M85.1x code per CDC ICD-10-CM Tabular List 2026.
04Is imaging required to bill M85.19?
ICD-10-CM code assignment is based on the provider's diagnostic statement, not solely on imaging. However, multi-site skeletal fluorosis virtually always requires radiographic or advanced imaging confirmation to support the diagnosis clinically and to satisfy payer medical necessity criteria.
05Which MS-DRG does M85.19 group to?
Per CMS MS-DRG v37.2, M85.19 groups to MDC 08 (Diseases & Disorders of the Musculoskeletal System & Connective Tissue) under the other musculoskeletal diagnoses grouping.
06Can M85.19 be used as a primary diagnosis for an orthopedic encounter?
Yes — M85.19 is a fully billable, specific code and may serve as the principal diagnosis when skeletal fluorosis at multiple sites is the condition chiefly responsible for the encounter. Sequence additional codes for complications (e.g., spinal stenosis, pathologic fracture) if they are separately addressed.
07Should I also code the fluoride exposure when using M85.19?
When the exposure source is known and clinically relevant, adding a secondary code for occupational or environmental exposure (such as a Z57 occupational exposure code) strengthens the medical record, supports risk adjustment, and can be useful for public health reporting, though it is not mandated by ICD-10-CM convention.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

  1. 01CDC ICD-10-CM Tabular List 2026
  2. 02CMS MS-DRG v37.2 Definitions Manual — MDC 08, https://www.cms.gov/icd10m/version372-fullcode-cms/fullcode_cms/P0667.html
  3. 03AAPC Codify — M85.19, https://www.aapc.com/codes/icd-10-codes/M85.19
  4. 04icd10data.com 2026 — M85.19, https://www.icd10data.com/ICD10CM/Codes/M00-M99/M80-M85/M85-/M85.19
  5. 05CMS ICD-10-CM Official Guidelines for Coding and Reporting FY2019 (general conventions), https://www.cms.gov/Medicare/Coding/ICD10/Downloads/2019-ICD10-Coding-Guidelines-.pdf

Mira AI Scribe

Mira AI Scribe captures the names of all involved skeletal sites, the documented fluoride exposure source, and key imaging findings (osteosclerosis, periosteal reaction, ligament calcification) from the encounter note. That specificity prevents a drop to the unspecified M85.10 code, closes the Excludes1 conflict risk, and ensures the claim supports medical necessity for multi-site imaging or specialist referral.

See how Mira captures M85.19 documentation

Related ICD-10 codes

Ready?

Ready to transform your orthopedic practice?

See how orthopedic practices are running documentation, billing, and operations on a single voice-first platform.

Get started for free